Nanotechnology offers several advantages in vaccine development and delivery. These include:
Improved bioavailability of the vaccine components. Enhanced targeted delivery to specific cells or tissues. Increased stability and shelf-life of vaccine formulations. Ability to elicit a stronger and more sustained immune response.